Single arm Phase I/II study of the safety, tolerability and efficacy of the Tocilizumab followed by cisplatin/docetaxel in patients with triple negative locally advanced breast cancer
2022-06-30
عنوان الدراسة
Single arm Phase I/II study of the safety, tolerability and efficacy of the Tocilizumab followed by cisplatin/docetaxel in patients with triple negative locally advanced breast cancer
داعم الدراسة
King Faisal Specialist Hospital and Research Centre
دواء الدراسة
TOCILIZUMAB (ACTEMRA)
رقم بروتوكول الدراسة
2181156
حالة الدراسة
Ongoing
موقع الدراسة
KFSH&RC-R
مرحلة الدراسة
1/2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。